Silver Book Fact

A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.

Setoguchi S, Glynn R, Avorn J, Mittleman M, et al. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis. JACC. 2008; 51(13): 1247-54. http://content.onlinejacc.org/cgi/content/abstract/51/13/1247?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Setoguchi&fulltext=Improvements+in+long-term+mortality&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW

Reference

Title
Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis
Publication
JACC
Publication Date
2008
Authors
Setoguchi S, Glynn R, Avorn J, Mittleman M, et al
Volume & Issue
Volume 51, Issue 13
Pages
1247-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.  
  • Through advances in risk-factor assessment, detection, and preventive strategies, the average age of acute myocardial infarction and heart failure patients has shifted around 10 to 15 years forward. One-year…  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.